|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.950 CAD | +2.43% |
|
0.00% | -23.38% |
| 06-15 | XORTX Therapeutics Appoints Mika Grasso as Co-CEO; Voluntarily Delisting from the TSX Venture Exchange | MT |
| 06-15 | Xortx Therapeutics Appoints Mika Grasso as Co-CEO; Provides Gout Drug Update | MT |
| Market Cap | 3.63M 2.58M 2.27M 2.11M 1.94M 250M 3.7M 25.18M 9.82M 122M 9.68M 9.47M 422M | P/E 2024 |
-1.02x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.8M 1.99M 1.75M 1.63M 1.5M 193M 2.86M 19.45M 7.59M 94.02M 7.47M 7.31M 326M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
91.78% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.43% | ||
| Current month | -7.81% | ||
| 1 month | +0.68% | ||
| 3 months | -17.60% | ||
| 6 months | -23.38% | ||
| Current year | -23.38% |
| 1 month | 2.88 |  | 3.2 |
| Current year | 2.42 | | 4.83 |
| 1 year | 2.42 | | 9.85 |
| 3 years | 2.42 | | 49.95 |
| 5 years | 2.42 | | 449.05 |
| 10 years | 2.42 | | 449.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mika Grasso
CEO | Chief Executive Officer | 28 | 2026-06-14 |
Allen Davidoff
CEO | Chief Executive Officer | 66 | 2018-01-08 |
Michael Bumby
DFI | Director of Finance/CFO | 62 | 2024-12-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Allen Davidoff
BRD | Director/Board Member | 66 | 2018-01-08 |
| Chairman | 69 | 2022-06-02 | |
George Scorsis
BRD | Director/Board Member | 50 | 2026-03-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/2/26 | Option | Director | 20,000 | 0.2873% | ||
| 2/2/26 | Other | Director | 0 | 0% | ||
| 1/7/26 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.43% | 0.00% | -55.97% | -92.87% | 3.62M | |
| +1.23% | +0.35% | +51.62% | +87.98% | 55.92B | |
| +1.33% | +7.37% | +63.44% | +68.59% | 56.67B | |
| -2.68% | -2.26% | -21.96% | -16.46% | 23.28B | |
| -0.88% | -2.21% | +2.33% | +417.74% | 23.28B | |
| -0.36% | -0.56% | +36.00% | -3.93% | 20.54B | |
| -1.34% | +0.43% | +24.93% | -30.33% | 17.78B | |
| -1.44% | -1.63% | +37.07% | +589.93% | 15.9B | |
| -1.30% | -9.92% | +160.67% | +284.37% | 14.64B | |
| -0.12% | -1.45% | +23.04% | +177.07% | 13.99B | |
| Average | -0.36% | +1.17% | +32.12% | +148.21% | 24.2B | |
| Weighted average by Cap. | -0.11% | +3.20% | +43.27% | +138.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.31M -2.35M -2.07M -1.92M -1.77M -228M -3.37M -22.97M -8.96M -111M -8.83M -8.64M -385M | -2.66M -1.88M -1.66M -1.54M -1.42M -183M -2.7M -18.42M -7.18M -89.03M -7.08M -6.92M -309M |
| Net Debt | -2.43M -1.73M -1.52M -1.41M -1.3M -167M -2.48M -16.88M -6.58M -81.61M -6.49M -6.35M -283M | -827K -587K -516K -480K -441K -56.85M -842K -5.74M -2.24M -27.73M -2.2M -2.16M -96.19M |
Employees
-
| Date | Price | Change | Volume |
|---|
Annual profits - Rate of surprise
- Stock Market
- Stocks
- XRTX Stock
Select your edition
All financial news and data tailored to specific country editions
